Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

E8 Pharmaceuticals, LLC v. Affymetrix, Inc., No. 13-1046 (Fed. Cir. Nov. 6, 2013)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 13-1046
Decided
November 6, 2013
Judge
Per curiam
Document
Nonprecedential Opinion
Length
2 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

We affirm the judgment of noninfringement in favor of Affymetrix, Inc. and Navigenics, Inc. We base our decision solely on our agreement with the district court’s construction of the phrase “randomly primed PCR-derived RCG.” We do not reach any other issues raised on appeal. AFFIRMED